Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

FSD Pharma announces Executive Informational Overview Report

Stockhouse Editorial
2 Comments| March 16, 2022

{{labelSign}}  Favorites
{{errorMessage}}



Coburg ON-based FSD Pharma Inc. (CSE: HUGE , OTC: HUGE, Forum) – a life sciences holding company dedicated to building a portfolio of assets and biotech solutions – has announced that Crystal Research Associates LLC has released an Executive Informational Overview (EIO) on FSD Pharma. The 58-page paid report can be found on FSD Pharma's website.

Or, click here for full news release.


About FSD Pharma

FSD Pharma Inc. is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences, Inc. – a wholly owned subsidiary – is focused on pharmaceutical research and development of its lead compound, ultra-micronized palmitoyl ethylamine (PEA) or FSD-PEA (formerly called FSD-201). Lucid Psycheceuticals Inc. (Lucid) – a wholly owned subsidiary – is focused on the research and development of its lead compounds, Lucid-PSYCH (formerly Lucid-201) and Lucid-MS (formerly Lucid-21-302). Lucid PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders.

New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.


FULL DISCLOSURE: FSD Pharma Inc. is a client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today